ArticleIEEE journal of translational engineering in health and medicine2025
MRI-Driven Longitudinal Studies of Hippocampal Alterations During the Initial Cognitive Decline.
Article in IEEE journal of translational engineering in health and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scalable CT-based prognostic modeling of dementia conversion in mild cognitive impairment.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on available magnetic resonance imaging (MRI) studies, hippocampal alteration is one of the hallmarks during cognitive decline. However, the longitudinal hippocampal morphometric changes during the initial cognitive decline are unclear. Exploring a validated biomarker with high clinical relevance is urgent. This work proposed an automated MRI-driven longitudinal hippocampal alteration analysis system (LHAAS), which consists of hippocampal segmentation, reconstruction, registration, multivariate morphometric feature extraction, and longitudinal analysis of hippocampal morphometric and volumetric differences between groups. LHAAS was applied on two groups: cognitive unimpaired (CU) participants who maintained cognitive unimpaired (non-Progressors), and participants who converted to MCI during the following four years (Progressors). LHAAS can detect and visualize subtle deformations in the bilateral hippocampus of CU progressors four years before they show initial cognitive decline. For CU progressors, hippocampal atrophy initially occurs at the CA1 subregion and then along with disease progression, spreading to the CA2-3 and Subiculum subregion, exhibiting a left-greater-than-right trend. The volumetric analyses showed similar results. Besides, hippocampal subregions highly correlated with clinical measurement were identified by correlation analysis. LHAAS can accurately reflect the small hippocampal subregional atrophy at preclinical AD. This proposed system can track the longitudinal hippocampal alterations in the early stages of AD and provide insights for early intervention. Clinical and Translational Impact Statement: LHAAS offers early detection of subtle hippocampal alterations at preclinical AD. This advance enables pathological research and timely interventions to potentially improve patient outcomes in clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.